Breakwater Capital Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.29M Buy
2,741
+4
+0.1% +$4.09K 0.39% 66
2026
Q1
$2.52M Sell
2,737
-11
-0.4% -$11.2K 0.34% 72
2025
Q4
$2.95M Sell
2,748
-54
-2% -$51.6K 0.41% 60
2025
Q3
$2.14M Sell
2,802
-15
-0.5% -$11.2K 0.32% 71
2025
Q2
$2.2M Sell
2,817
-113
-4% -$87.8K 0.36% 65
2025
Q1
$2.42M Buy
2,930
+49
+2% +$40.8K 0.43% 55
2024
Q4
$2.22M Sell
2,881
-193
-6% -$160K 0.44% 56
2024
Q3
$2.72M Sell
3,074
-72
-2% -$64.7K 0.55% 49
2024
Q2
$2.85M Buy
3,146
+221
+8% +$177K 0.65% 40
2024
Q1
$2.28M Buy
2,925
+7
+0.2% +$4.98K 0.57% 47
2023
Q4
$1.84M Buy
2,918
+71
+2% +$41.4K 0.52% 53
2023
Q3
$1.58M Buy
2,847
+91
+3% +$46.9K 0.54% 48
2023
Q2
$1.29M Buy
2,756
+261
+10% +$109K 0.47% 62
2023
Q1
$857K Buy
2,495
+57
+2% +$19.2K 0.36% 72
2022
Q4
$892K Buy
+2,438
New +$864K 0.47% 59

Other funds holding LLY

Breakwater Capital Group's LLY Position: Q2 2026 in Review

Breakwater Capital Group increased its Eli Lilly (LLY) stake by 0.15% in Q2 2026, buying an estimated $4.09K and bringing the position to 2,741 shares worth $3.29M. The position accounts for 0.39% of the portfolio, ranked #66.

Breakwater Capital Group first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Breakwater Capital Group held 2,741 shares of Eli Lilly worth $3.29M as of Q2 2026.
  • Breakwater Capital Group bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 0.39% of Breakwater Capital Group's portfolio in Q2 2026, its #66 holding.
  • Breakwater Capital Group first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Breakwater Capital Group's 13F filing for Q2 2026, filed 8 Jul 2026.